INSITE technology uses ultrasound-guided delivery of hepatocytes in hydrogel microspheres to create vascularizable scaffolds, potentially reducing the need for liver transplants and addressing donor s...
Recent studies reveal mesenchymal stromal cells transfer healthy mitochondria via endocytosis, combating mitochondrial dysfunction in aging and diseases like osteoporosis, with fenofibrate enhancing e...
Stanford’s March 2024 study shows electric field bioprinting improves muscle fiber alignment by 40%, advancing regenerative medicine for injuries and aging, with potential clinical applications ...
Recent studies show targeted epigenetic reprogramming with Yamanaka factors rejuvenates neurons, reversing cognitive decline in aged mice and reducing Alzheimer’s markers, with AI enhancing safe...
The FDA has greenlit the first human trial of ER-100, a partial epigenetic reprogramming therapy targeting age-related eye diseases, marking a pivotal step in anti-aging and regenerative medicine. A l...
A Nature Communications study shows engineered small extracellular vesicles with platelet proteins restore heart rhythm in rats, offering a safer alternative to pacemakers and gene therapies. Innovati...
Biotech advancements in thymus regeneration, like TECregen’s therapies, show promise in rejuvenating immune function for aging populations, addressing delivery challenges and ethical considerati...
Stanford Medicine study finds inhibiting 15-PGDH enzyme regenerates cartilage in aged mice, offering a non-invasive osteoarthritis treatment that could reduce joint replacements and improve life quali...
Recent phase 2b trials show stem cell-derived patches significantly improve vision in dry AMD patients, with 40% achieving notable gains, marking a leap in regenerative ophthalmology. Breakthrough ste...
Recent findings reveal that long-term MSC-EV treatment enhances cognitive function in aged rhesus monkeys by improving white matter integrity, offering a cost-effective alternative to stem cell therap...
